Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

​ Conditions: Hereditary Angioedema (HAE); Hereditary Angioedema – Type 1; Hereditary Angioedema – Type 2; HAE

Interventions: Drug: ADX-324 Dose Level 1; Drug: ADX-324 Dose Level 2

Sponsors: ADARx Pharmaceuticals, Inc.

Not yet recruiting Conditions: Hereditary Angioedema (HAE); Hereditary Angioedema – Type 1; Hereditary Angioedema – Type 2; HAE
Interventions: Drug: ADX-324 Dose Level 1; Drug: ADX-324 Dose Level 2
Sponsors: ADARx Pharmaceuticals, Inc.
Not yet recruiting